Loading...
XSHE
002144
Market cap255mUSD
Jul 09, Last price  
9.79CNY
1D
-0.61%
1Q
-35.55%
Jan 2017
-56.72%
IPO
-69.68%
Name

Hongda High-Tech Holding Co Ltd

Chart & Performance

D1W1MN
XSHE:002144 chart
P/E
40.01
P/S
3.52
EPS
0.24
Div Yield, %
0.51%
Shrs. gr., 5y
0.16%
Rev. gr., 5y
-3.96%
Revenues
491m
-20.56%
302,546,229298,377,653409,467,457587,782,215628,716,490585,872,263545,115,308526,648,972569,692,355634,755,296638,464,743543,319,831461,677,366601,036,760601,036,760579,374,030579,374,029535,183,324618,296,226491,198,936
Net income
43m
+54.77%
6,943,12111,239,46140,097,23569,994,660114,718,98281,200,223117,522,011124,793,882100,812,18096,547,56290,848,43082,527,81963,951,71964,866,46464,866,47079,684,52179,684,52582,253,03627,944,49743,248,412
CFO
80m
-26.02%
39,984,21211,484,69863,846,89251,287,623166,295,131096,407,55080,550,579118,942,75840,385,838138,963,106147,874,69836,273,065124,780,70388,291,794108,013,10582,286,51875,228,177107,964,43779,873,926
Dividend
Jun 20, 20250.05 CNY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Hongda High-Tech Holding Co.,Ltd. is a Chinese enterprise with a diverse operational scope, active in warp-knitting, healthcare technology (medical devices), commercial trading, and financial investments. Its textile division specializes in manufacturing fabrics for automotive interiors and general apparel. Additionally, the company's medical device segment offers a variety of products designed for numerous organs, including the liver, gallbladder, spleen, kidneys, pancreas, heart, thyroid, breasts, bladder, and uterine adnexa. These automotive interior textiles are exported worldwide, with key markets including the United States, Germany, and Japan. Established in 1985, the firm was initially known as Zhejiang Hongda Warp Knitting Co., Ltd. before officially adopting its current name, Hongda High-Tech Holding Co.,Ltd., in August 2010. Its headquarters are situated in Haining, China.
IPO date
Aug 03, 2007
Employees
Domiciled in
CN
Incorporated in
CN

Valuation

Title
CNY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑002022‑122022‑002021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT